Synapsoft logo
AI Insights from Disclosures
Searching...
SAMSUNG EPIS HOLDINGS Co., Ltd. 0126Z0
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
SAMSUNG EPIS HOLDINGS Co., Ltd. is a holding company under the 'Monopoly Regulation and Fair Trade Act,' and is a 'bio investment holding company' that currently holds two subsidiaries, Samsung Bioepis and Epis NexLab. Its subsidiary Samsung Bioepis engages in the development and commercialization of biopharmaceuticals as its core business, while Epis NexLab focuses on the development of next-generation bio technology platforms.
Representative Director Kim Gyeonga
Founded November 3, 2025
Corporation Type KOSPI
Industry Classification Activities of holding companies
Corporate number 12011-0149508
Business number 759-88-03316
Phone Number 0327280114
Fax Number
Company Address 76 Songdogyoyuk-ro, Yeonsu-gu, Incheon

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant